Mofebutazone sodium is the monophenyl analog of phenylbutazone (DPB), an anti-inflammatory compound. Mofebutazone sodium is used in asthma research[1][2].
References
[1] F.T. Delbeke, et al. Determination of mofebutazone and its 4-hydroxy metabolite in plasma and urine by high-performance liquid chromatography. Journal of Chromatography A. Volume 369, 1986, Pages 440-444. [2] Khayyal MT,et al. Tolerability of mofebutazone in asthmatic patients. Int J Clin Pharmacol Res. 1995;15(4):145-51. PMID:8871264
4-butyl-1-phenylpyrazolidine-3,5-dione, sodium salt Supplier
